Evidence map›Paper›PMID 39420527›Full record

ArticleJournal of clinical apheresis2024

Development of a Uniform Apheresis Case Report Form for Standardized Collection of Apheresis Data.

Andrew D Johnson, Zbigniew M Szczepiorkowski, Rasheed A Balogun, Oliver Karam, Marianne Nellis, Jennifer Schneiderman, Joseph Schwartz, Jeffrey L Winters, Yanyun Wu, Tomas Armendariz and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical apheresis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Andrew D JohnsonDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
Zbigniew M SzczepiorkowskiDepartment of Laboratory Medicine and Pathology and Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Rasheed A BalogunDivision of Nephrology, University of Virginia, Charlottesville, Virginia, USA.
Oliver KaramPediatric Critical Care Medicine, Yale School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0001-6606-1736
Marianne NellisDivision of Pediatric Critical Care Medicine, Weill Cornell Medicine, New York, New York, USA.
Jennifer SchneidermanAnn & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Joseph SchwartzDepartment of Pathology, Hematopathology & Laboratory Medicine, Moffitt Cancer Center, Tampa, Florida, USA.
Jeffrey L WintersDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Yanyun WuDepartment of Laboratory Medicine and Pathology, University of Miami, Miami, Florida, USA.
Tomas ArmendarizUniversity of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID https://orcid.org/0000-0002-7379-4003
Edwin BurgstalerDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Laura CollinsDepartment of Pathology, University of Iowa, Iowa City, Iowa, USA.
Kira GeileSt. Louis Children's Hospital and Washington University School of Medicine, St. Louis, Missouri, USA.
Katerina PavenskiDepartment of Medicine and Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Amber P SanchezDivision of Nephrology and Hypertension, Department of Medicine, University of California san Diego, San Diego, California, USA.
Volker WittDepartment for Pediatrics, St. Anna Kinderspital, Medical University of Vienna, Vienna, Austria.
Amutha MuthusamyMasonic Cancer Center-Cancer Research Translational Initiative, University of Minnesota, Minneapolis, Minnesota, USA.
Thomas PedersonMasonic Cancer Center-Clinical Informatics Shared Services and Best Practices Informatics, Core-Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota, USA.
Vidhyalakshmi RameshMasonic Cancer Center-Clinical Informatics Shared Services and Best Practices Informatics, Core-Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota, USA.
Mai ThaoMasonic Cancer Center-Cancer Research Translational Initiative, University of Minnesota, Minneapolis, Minnesota, USA.
Therese ChlebeckDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
Nicole D ZantekDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0001-5776-6400

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UM1TR004405 · NCATS · UNIVERSITY OF MINNESOTA · PI Bruce R Blazar, Damien A Fair · 2023 to 2026
$30.8M
NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR002494NCATS NIH HHS UM1 TR004405University of Minnesota UL1TR002494, UM1TR004405University of Minnesota, Department of Laboratory Medicine and Pathology, Innovation Initiatives grant
6 · The paper itself

Abstract

Apheresis is performed worldwide for an increasing number of indications. The development of common data elements (CDE) for apheresis related areas may facilitate conduct of new research, enhance quality initiatives including benchmarking, and improve patient care. This report describes the systematic development of the Uniform Apheresis Case Report Form (UACRF) as part of the Apheresis in the United States (ApheresUS) program. A consensus panel of 17 diverse experts in apheresis, related specialties, and electronic case report form (eCRF), and database development was assembled. The panel met via online conferencing from November 17, 2020 to December 1, 2021. A draft document was posted online for public comment from October 11, 2021 to November 10, 2021. Feedback was collected using an online survey tool. The consensus panel revised the UACRF. This version was converted to an eCRF with additional changes made to improve usability in this format. The final version of the UACRF was created on August 24, 2023. The UACRF contains 16 modules: procedure and subject eligibility, patient demographics, general procedure information, laboratory parameters, vascular access, common procedure elements, eight procedure specific modules (mononuclear cell collection and seven therapeutic modalities), outcomes, and site information. A total of 137 data elements were created, including 57 with one or more subelements. The UACRF is the first systematic attempt to develop CDE for therapeutic apheresis and white blood cell collections. Further validation of the UACRF is necessary to confirm the tool's ability to collect the relevant data elements and determine the usability of the form.

Indexed as

Blood Component RemovalConsensusData CollectionHumansUnited Statesapheresiscase report formconsensus paneldata elements

Identifiers

PMID39420527
PMCPMC11523286

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.